SEARCH RESULT

Total Matching Records found : 51

Hope of cheap solar water tool -GS Mudur

-The Telegraph A team of Indian engineers has designed a prototype low-cost solar-heated water desalination unit that can produce about five litres of drinking water each day and is intended for use by rural households. The desalination unit may be used to turn brackish groundwater fit for drinking at any place with abundant solar energy, the team of engineers, who are from the National Institute of Technology in Kurukshetra and an engineering...

More »

New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...

More »

SMS, RTI potent tools of drug companies fighting patent battle -Soma Das

-The Economic Times NEW DELHI: As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost generic versions of their patented products in India. Innovator drugmakers, who used to strike with patent suits after generic drugmakers released their versions in the market, have started gleaning information from text messages sent...

More »

Most big patented drugs skip India -Rupali Mukherjee

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...

More »

CAG raps Bihar govt for 'fiscal indiscipline'

-The Times of India PATNA: The Bihar government, which keeps crying for more central assistance, could not spend Rs 1472.61 crore in 2012 and surrendered 100 per cent funds in 192 schemes, depriving the beneficiaries of the benefits, according to the CAG report for 2011-12 presented in state assembly on Tuesday. Central funds for several schemes also remained unutilized, it said. The CAG also regretted the lack of objective planning in utilization...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close